Lexeo Therapeutics, Inc. (LXEO)
NASDAQ:LXEO
US Market
Holding LXEO?
Track your performance easily

Lexeo Therapeutics, Inc. (LXEO) Financial Statements

108 Followers

Lexeo Therapeutics, Inc. Financial Overview

Lexeo Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $-2.705; its P/E ratio is -2.84; Lexeo Therapeutics, Inc. is scheduled to report earnings on March 17, 2025, and the estimated EPS forecast is $-0.77. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Jun 23Dec 22
Income Statement-
Total Revenue----
Gross Profit----
EBIT$ -29.45M$ -21.20M--
EBITDA$ -28.94M$ -20.71M--
Net Income Common Stockholders$ -29.49M$ -21.24M--
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 157.02M$ 174.98M$ 45.54M$ 77.33M
Total Assets$ 173.87M$ 192.01M$ 64.94M$ 97.08M
Total Debt$ 10.40M$ 10.85M$ 12.66M$ 13.48M
Net Debt$ -146.62M$ -164.13M$ -32.88M$ -63.85M
Total Liabilities$ 34.54M$ 27.06M$ 23.52M$ 25.00M
Stockholders Equity$ 139.33M$ 164.95M$ 41.41M$ 72.08M
Cash Flow-
Free Cash Flow$ -17.89M$ -20.36M--
Operating Cash Flow$ -17.81M$ -20.15M--
Investing Cash Flow$ -83.00K$ -218.00K--
Financing Cash Flow$ -72.00K$ 291.00K--
Currency in USD

Lexeo Therapeutics, Inc. Earnings and Revenue History

Lexeo Therapeutics, Inc. Debt to Assets

Lexeo Therapeutics, Inc. Cash Flow

Lexeo Therapeutics, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis